When was Predictive Oncology founded?

Predictive Oncology was founded in 2002 and raised its 1st funding round 6 years after it was founded.

Where is Predictive Oncology located?

Predictive Oncology is headquartered in Eagan, United States.

Who is the current CEO of Predictive Oncology?

Carl Schwartz of Predictive Oncology.

How many employees does Predictive Oncology have?

As of Apr 30, 2026, the latest employee count at Predictive Oncology is 15.

Is Predictive Oncology a funded company?

Predictive Oncology is a funded company, having raised a total of $43M across 9 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Nov 11, 2008.

When was the latest funding round of Predictive Oncology?

Predictive Oncology's latest funding was a $***** Post IPO round on Oct 07, 2025, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.24B in funding in 2026 to date.

What is the annual revenue of Predictive Oncology?

Annual revenue of Predictive Oncology is between $1M and $10M as on Dec 31, 2024

Where does Predictive Oncology rank among its competitors?

Predictive Oncology ranks 4th amongst 31 active competitors, of which 11 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Waypoint, which secured $20M in Jun, 2026.

Who are the top competitors of Predictive Oncology?

Predictive Oncology's top competitors include Noetik, Waypoint and Pathos. Among them, Waypoint secured the most recent funding round in June, 2026.

Predictive Oncology - 2026 Company Profile, Team, Funding, Competitors & Financials

Predictive Oncology is an acquired company based in Eagan (United States), founded in 2002. It operates as an AI-based cancer diagnostic and precision medicines platform. Predictive Oncology has raised $43M in funding from Longitude Capital. The company has 31 active competitors, including 11 funded and 2 that have exited. Its top competitors include companies like Noetik, Waypoint and Pathos.

Company Details

AI-based cancer diagnostic and precision medicines platform. The company has developed an AI-based assessment and inventory for precision medicine and treatment planning. The system uses Multi-omics models analysis and diagnostic technology for decision making.

Website: predictive-oncology.com
Social
Email ID: *****@predictive-oncology.com
Phone Number: +1 **********

Key Metrics

Founded Year

2002

Location

Eagan, United States

Stage

Acquired

Total Funding

$43M in 9 rounds

Latest Funding Round

Post IPO, Oct 07, 2025, $*****

Investors

Longitude Capital & 7 more

Ranked

4^th among 31 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2024

Employee Count

15 as on Apr 30, 2026

Investment & Acquisitions

zPREDICTA & 4 more

Similar Companies

Noetik & 32 more

Exit Details

Acquired by Renovaro (Jan 06, 2024)

View Predictive Oncology's full profile

Predictive Oncology is associated with 8 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SKYLINE MEDICAL INC. CIN: 1446159 , United States, Active	Dec 13, 2017	$1M - $10M (As on Dec 31, 2024)	31 (As on Dec 31, 2022)	-
Foundation Medicine, Inc. CIN: 1488613 , United States, Active	Nov 11, 2009	$100M - $500M (As on Dec 31, 2017)	1707 (As on Dec 31, 2022)	-
Predictive Oncology Inc CIN: 33-1007393 , United States, Active	Dec 10, 2013	-	31 (As on Dec 31, 2022)	-
Cvergenx, Inc CIN: 270275991 , United States, Active	Apr 14, 2010	-	-	-
Predictive Oncology Inc. CIN: 1446159 , United States, Active		$1M - $5M (As on Jun 02, 2022)	-	-
PROCTER & GAMBLE CO CIN: 80424 , United States, Active	Jun 29, 1994	$1B+ (As on Jun 30, 2025)	108000 (As on Jun 30, 2024)	-
Pathai, Inc. CIN: 811778508 , United States, Active	Dec 31, 2015	-	161 (As on Dec 31, 2024)	-
PRECISION THERAPEUTICS CIN: 251762624 , United States, Active	Dec 31, 1999	-	13 (As on Dec 31, 2018)	-

Predictive Oncology got acquired by Renovaro on Jan 06, 2024.

Click here to take a look at Predictive Oncology's acquisition in detail

Predictive Oncology has raised a total funding of $43M over 9 rounds. Its first funding round was on Nov 11, 2008. Predictive Oncology has 8 institutional investors.

Here is the list of recent funding rounds of Predictive Oncology:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 07, 2025	2283745	Post IPO	6783572	1697993	3708263	5880204
Aug 26, 2025	2648383	Post IPO	2485601	3612306	4022819	3691387
May 18, 2022	9970093	Post IPO	4939778	8408153	6734695	2864356

Access funding benchmarks and valuations. Sign up today!

View details of Predictive Oncology's funding rounds and investors

Predictive Oncology's employee count trend

Predictive Oncology has 15 employees as of Apr 26. Here is Predictive Oncology's employee count trend over the years:

Employee count trend for Predictive Oncology

Uncover Predictive Oncology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Predictive Oncology include Noetik, Waypoint and Pathos. Here is the list of Top 10 competitors of Predictive Oncology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Noetik 2022, San Francisco (United States), Series A	Developer of AI-driven platform for cancer immunotherapy discovery and development	$62M	Polaris Partners, DCVC & 19 others	62/100
2nd	Waypoint 2021, New York City (United States), Series A	Digital cell therapy platform for providers	$34.5M	Amplify Partners, Hummingbird Ventures & 7 others	61/100
3rd	Pathos 2022, Chicago (United States), Series D	Provider of AI based drug discovery platform for drug development	$345M	New Enterprise Associates, Revolution & 2 others	57/100
4th	Predictive Oncology 2002, Eagan (United States), Acquired	AI-based cancer diagnostic and precision medicines platform	$43M	Quaker Partners Management, Longitude Capital ... & 6 others	56/100
5th	Transition Bio 2020, Cambridge (United States), Series B	Developer of a technology platform for the analysis of biomolecular condensate	$69.3M	Northpond Ventures, Lifeforce Capital & 3 others	55/100
6th	Econic Biosciences 2022, London (United Kingdom), Series B	Developer of a platform for the discovery and development of targeted therapies for cancer	$20M	Genelle Capital, SR One	48/100
7th	Tailor Bio 2020, Cambridge (United Kingdom), Funding Raised	Developer of targeted therapies for cancers with chromosomal instability	-	Acequia Capital, Illumina & 9 others	47/100
8th	Function Oncology 2018, San Diego (United States), Series A	Developer of therapeutics to treat cancer	$28M	Andreessen Horowitz, S32 & 3 others	45/100
9th	Meliora Therapeutics 2021, San Francisco (United States), Seed	Provider of machine learning-driven drug discovery platform for cancer	$11M	HOF Capital, Zhen Fund & 12 others	42/100
10th	Okomera 2020, Paris (France), Seed	Developer of a device for in vitro cancer testing using a microfluidic chip	$11.2M	Resonance, Polytechnique Ventures & 4 others	42/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Predictive Oncology's competitors? Click here to see the top ones

Predictive Oncology has not made any investments yet. Predictive Oncology has made 5 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Dec 01, 2021	Acquisition	zPREDICTA	2014	San Jose (United States)
Jul 06, 2020	Acquisition	BioDtech	2003	Birmingham (United States)
May 15, 2020	Acquisition	Soluble BioScience	2008	Birmingham (United States)